
Beren Therapeutics – SUCCESS PAGE – September 17, 2026
Beren Therapeutics is developing a new class of medicines targeting numerous neurodegenerative diseases, including Alzheimer’s.

Beren Therapeutics is developing a new class of medicines targeting numerous neurodegenerative diseases, including Alzheimer’s.

A new therapeutic modality designed to directly target and destroy disease gene sequences rather than simply treat the symptoms of a disease

More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution

abioSCOPE® is point-of-care platform that measures a biomarker that may begin rising 48 to 72 hours before a clinical diagnosis for sepsis

A first-in-class oral therapy for cancer, neuroinflammatory, and autoimmune disease with both FDA Fast Track and Orphan Drug designations

How leading scientists determine which discoveries have the potential to become meaningful new therapies.

A new therapeutic modality designed to directly target and destroy disease gene sequences rather than simply treat the symptoms of a disease

Kesmalea is developing an oral therapeutic designed to selectively eliminate a protein strongly associated with Alzheimer’s progression

A first-in-class oral therapy for cancer, neuroinflammatory, and autoimmune disease with both FDA Fast Track and Orphan Drug designations

HDT Bio is developing a new immune-maintenance therapy for breast cancer patients designed to prevent relapse years after successful treatment.

Kesmalea is developing an oral therapeutic designed to selectively eliminate a protein strongly associated with Alzheimer’s progression

Brook is giving health systems the technology, clinical teams, and infrastructure to support patients beyond the traditional office visit
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |